Benzinga's Top Initiations

Barclays initiated coverage on

with a Overweight rating. The target price for Bruker is set to $30. Bruker shares closed at $25.98 on Monday. Analysts at BTIG Research initiated coverage on

with a Buy rating. The target price for bluebird bio is set to $72. bluebird bio shares closed at $46.22 on Monday. Analysts at Wedbush initiated coverage of

with a Outperform rating. The target price for Aimmune Therapeutics is set to $42. Aimmune Therapeutics shares closed at $16.00 on Monday. Analysts at Barclays initiated coverage on

with a Equal-weight rating. The target price for Waters Corporation is set to $125. Waters Corporation shares closed at $120.31 on Monday. Analysts at Sterne Agee CRT initiated coverage on

with a Neutral rating. Polaris Industries shares closed at $87.91 on Monday. Analysts at H.C. Wainwright initiated coverage on

with a Buy rating. The target price for Juniper Pharmaceuticals is set to $18. Juniper Pharmaceuticals shares closed at $7.49 on Monday. Analysts at Hovde Group initiated coverage on

with a Outperform rating. The target price for Sussex Bancorp is set to $15.25. Sussex Bancorp shares closed at $13.20 on Monday. Sterne Agee CRT initiated coverage on

with a Buy rating. Flagstar Bancorp shares closed at $19.20 on Monday. H.C. Wainwright initiated coverage on

with a Buy rating. The target price for Celldex Therapeutics is set to $25. Celldex Therapeutics shares closed at $6.80 on Monday.